Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Oxurion's Anti-PIGF Antibody Disappoints in Diabetic Macular Edema

Tue, 08/20/2019 - 9:02am

The primary endpoint was missed in a Phase IIa study of Oxurion’s THR-317 in diabetic macular edema, but vision did...

      Related Stories 

AZ's Dapagliflozin Impresses In Topline Phase III Heart Failure Study

Tue, 08/20/2019 - 5:39am

AstraZeneca’s SGLT2 inhibitor has grabbed attention for its potential role in chronic heart failure patients, with or without type 2...

      Related Stories 

Sarepta Surprised By CRL For Exon 53-Skipping DMD Drug Golodirsen

Mon, 08/19/2019 - 3:56pm

The US FDA issued a complete response letter rejecting golodirsen based on risk of infection at intravenous infusion ports and...

      Related Stories 

Vanda Not Ready To Give Up On Jet Lag Indication For Hetlioz Despite CRL

Mon, 08/19/2019 - 1:59pm

Complete response letter follows July deficiencies letter that made approval seem highly unlikely. Vanda called the setback perplexing and said...

      Related Stories 

Juvenescence Raises $100M To Advance Anti-Aging Programs

Mon, 08/19/2019 - 7:34am

The financing, which brings the total raised by Juvenescence to $165m, comes as longevity R&D programs supported by the company...

      Related Stories 

US Is Land Of Opportunity For Zealand

Mon, 08/19/2019 - 7:34am

The Danish group is beefing up its operations across the Atlantic as it prepares filings for dasiglucagon and glepaglutide.

      Related Stories 

Pipeline Watch: Phase III Results With Osimertinib, Ripretinib And Evinacumab

Mon, 08/19/2019 - 2:59am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Europe's Biotechs Gathering Steam With Filgotinib Filing

Fri, 08/16/2019 - 8:41am

Galapagos is another step closer to commercializing its products with its lead candidate, filgotinib, now under the gaze of EU...

      Related Stories 

Interview: Mereo All Set For Key Setrusumab Data

Fri, 08/16/2019 - 8:01am

Although far from a one-product company, data in Q4 will be key to whether the brittle bone drug could become...

      Related Stories 

Mallinckrodt’s Phase III Kidney Failure Trial Hits Primary Endpoint

Fri, 08/16/2019 - 6:06am

The data position Mallinckrodt to file for US FDA approval of terlipressin early next year. Mallinckrodt thinks the drug could...

      Related Stories 

Glenmark On Course For Xolair Biosimilar Deal, US Capital Raise For Innovation

Fri, 08/16/2019 - 12:23am

Glenmark appears close to sewing up a deal for its biosimilar version of Novartis/Genentech's Xolair amid the firm's ongoing focus...

      Related Stories 

Start-Up Quarterly Statistics: Financings Fell 17% To $2.84bn In Q2

Thu, 08/15/2019 - 9:34am

A review of second quarter biopharma start-up deal-making and financing activity from Strategic Transactions showed a quarter-over-quarter drop in dollars...

      Related Stories 

Janssen's Imbruvica Leads CLL Market Expansion In Europe

Thu, 08/15/2019 - 8:45am

Imbruvica is keeping ahead of potential competitors in Europe by expanding its use in patients with chronic lymphocytic leukemia and...

      Related Stories 

Pages